Analysis of the peroxisome proliferator activated receptor γ (PPARγ) gene in HAIRAN syndrome with obesity

Clinical Endocrinology

Volumn 52, Issue 4, 2000, Pages 479-485

  Globerman, Hadas ^a   Zauberman, Y ^a   Makarov, T ^a   Beamer, B A ^b   Yen, C J ^b   Shuldiner, A R ^c   Harel, C ^a   Karnieli, E ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISRAEL; MALE; MISSENSE MUTATION; OBESITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACANTHOSIS NIGRICANS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; LIVER; MALE; OBESITY; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SYNDROME; TRANSCRIPTION FACTORS;

EID: 0034099418     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00950.x     Document Type: Article

References (27)

1. Abbott, W.G.H. & Foley, J.E. (1987) Comparison of body composition, adipocyte size, and glucose and insulin concentrations in Pima Indian and Caucasian children. Metabolism, 36, 576-579.
2. Beamer, B.A., Negri, C., Yen, C.J., Gavrilova, O., Rumberger, J.M., Durcan, M.J., Yarnall, D.P., Hawkins, A.L., Griffin, C.A., Burns, D.K., Roth, J., Reitman, M. & Shuldiner, A.R. (1997) Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene. Biochemical and Biophysical Research Communications, 233, 756-759.
3. Beamer, B.A., Yen, C.J., Andersen, R.E., Muller, D., Elahi, D., Cheskin, L.J., Andres, R., Roth, J. & Shuldiner, A.R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes, 47, 1806-1808.
4. Cohen, P., Harel, C., Bergman, R., Daoud, D., Pam, Z., Barzilai, N., Armoni, M. & Karnieli, E. (1990) Insulin resistance and acanthosis nigricans: evidence for a postbinding defect in vivo. Metabolism, 39, 1006-1011.
5. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Markku, L., Fujimoto, W. & Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics, 20, 284-287.
6. Dunaif, A., Scott, D., Finegood, D., Quintana, B. & Whitcomb, R. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 81, 3299-3306.
7. Elbrecht, A., Chen, Y., Cullinan, C.A., Hayes, N., Leibowitz, M.D., Moller, D.E. & Berger, J. (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 (cDNA). Biochemical and Biophysical Research Communications, 224, 431-437.
8. Flier, J.S., Eastman, R.C., Minaker, K.L., Matteson, D. & Rowe, J.W. (1985) Acanthosis nigricans in obese women with hyperandrogenism characterization of an insulin-resistant state distinct from the type A and B syndromes. Diabetes, 34, 101-107.
9. Globerman, H. & Karnieli, E. (1998) Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance). International Journal of Obesity, 22, 349-353.
10. Hallakou, S., Doare, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthoult, M.F., Dugail, I., Morin, J., Auwerx, J. & Ferre, P. (1997) Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes, 46, 1393-1399.
11. Henry, R.R. (1997) Thiazolidinediones. Endocrinology and Metabolism Clinics of North America, 26, 553-573.
12. Hotta, K., Gustafson, T.A., Yoshioka, S., Ortmeyer, H.D., Bodin, N.L. & Hansen, B.C. (1998) Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys. International Journal of Obesity, 22, 1000-1010.
13. Nolan, J.J., Ludvik, B., Beerdsen, P., Joyce, M. & Olefsky, J. (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. New England Journal of Medicine, 331, 1188-1193.
14. Okazawa, H., Mori, H., Tamori, Y., Satashi, A., Niki, T., Masugi, J., Masatoshi, K., Kubota, T., Shinoda, H. & Kasuga, M. (1997) No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes, 46, 1904-1906.
15. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
16. Peters, E.J., Stuart, C.A. & Prince, M.J. (1986) Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism, 35, 807-813.
17. Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W. & Kahn, C.R. (1998) Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine, 339, 953-959.
18. Rizza, R.A., Mandarino, L.J. & Gerich, J.E. (1981) Dose-response characteristics for effects of insulin on production and utilization of glucose in man. American Journal of Physiology, 240, E630-E639.
19. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning. 2nd edn, pp. 9.16-19.19. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Spiegelman, B.M. & Flier, J.S. (1996) Adipogenesis and obesity: rounding out the big picture. Cell, 87, 377-389.
21. Spiegelman, B.M. (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514.
22. Tontonoz, P., Hu, E. & Spiegelman, B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 79, 1147-1156.
23. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I. & Spiegelman, B.M. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development, 8, 1224-1234.
24. Vidal-Puig, A.J., Considine, R.V., Jimenez-Linan, M., Werman, A., Pories, W.J., Caro, J.F. & Flier, J.S. (1997) Peroxisome proliferator-aclivated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation, 99, 2416-2422.
25. Vigouroux, C., Fajas, L., Khallouf, E., Meier, M., Gyapay, G., Lascols, O., Auwerx, J., Weissenbach, J., Capeau, J. & Magre, J. (1998) Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes, 47, 490-492.
26. Werman, A., Hollenberg, A., Solanes, G., Bjørbaek, C., Vidal-Puig, A.J. & Flier, J.S. (1997) Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. Journal of Biological Chemistry, 272, 20230-20235.
27. Yen, C.J., Beamer, B.A., Negri, C, Silver, K., Brown, K.A., Yarnall, D.P., Burns, D.K., Roth, J. & Shuldiner, A.R. (1997) Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochemical and Biophysical Research Communications, 241, 270-274.